(Q71056781)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8620671%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

title

The effect of mild or moderate hepatic impairment (cirrhosis) on the pharmacokinetics of zileuton (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8620671%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

1 reference

W M Awni

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8620671%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

J H Cavanaugh

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8620671%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

R A Braeckman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8620671%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

S Y Chu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8620671%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

K J Patterson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8620671%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

J M Machinist

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8620671%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

G R Granneman

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8620671%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

publication date

1 January 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8620671%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacokinetics

15 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8620671%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

volume

29 Suppl 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8620671%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

page(s)

49-61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8620671%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00003088-199500292-00008

15 October 2019

exact match

0 references

cites work

The pharmacokinetics of zileuton in healthy young and elderly volunteers.

1 reference

12 December 2020

Determination of a new 5-lipoxygenase inhibitor, zileuton, and its inactive N-dehydroxylated metabolite in plasma by high performance liquid chromatography

1 reference

12 December 2020

Superiority of the Child-Pugh classification to quantitative liver function tests for assessing prognosis of liver cirrhosis

1 reference

12 December 2020

Reduced Allergen-Induced Nasal Congestion and Leukotriene Synthesis with an Orally Active 5-Lipoxygenase Inhibitor

1 reference

12 December 2020

5-lipoxygenase inhibitory activity of zileuton

1 reference

12 December 2020

Phase II study of the safety and efficacy of a 5-lipoxygenase inhibitor in patients with ulcerative colitis

1 reference

12 December 2020

The effects of a 5-lipoxygenase inhibitor on asthma induced by cold, dry air

1 reference

12 December 2020

5-lipoxygenase inhibitors and their anti-inflammatory activities

1 reference

12 December 2020

Glucuronidation of zileuton (A-64077) by human hepatic microsomes

1 reference

12 December 2020

Effect of Zileuton (A-64077) on the 5-lipoxygenase activity of human whole bloodex vivo

1 reference

12 December 2020

The discovery and development of zileuton: An orally active 5-lipoxygenase inhibitor

1 reference

12 December 2020

Pharmacokinetics, safety, and ability to diminish leukotriene synthesis by zileuton, an inhibitor of 5-lipoxygenase

1 reference

12 December 2020

The pharmacokinetics of single oral doses of zileuton 200 to 800mg, its enantiomers, and its metabolites, in normal healthy volunteers

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of zileuton after oral administration of single and multiple dose regimens of zileuton 600mg in healthy volunteers.

1 reference

12 December 2020

Effect of a 5-lipoxygenase inhibitor on leukotriene generation and airway responses after allergen challenge in asthmatic patients

1 reference

12 December 2020

Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases

1 reference

12 December 2020

In vitro plasma protein binding of zileuton and its N-dehydroxylated metabolite

1 reference

12 December 2020